Seramune I.V.
This page contains information on Seramune I.V. for veterinary use.The information provided typically includes the following:
- Seramune I.V. Indications
- Warnings and cautions for Seramune I.V.
- Direction and dosage information for Seramune I.V.
Seramune I.V.
This treatment applies to the following species:equine IgG
dose: administer 250ml intravenously in no less than 30 minutes; repeat as clinical conditions indicate, within first 120 hours of life
● store refrigerated at 2 - 8° C/35 - 46° F; do not freeze
● once opened, use entire contents as directed above
to facilitate use, the following measures are suggested:
● dilute product into 1 - 2 liters of lactated ringers
● warm solution to body temperature
● premedicate with an anti-inflammatory and / or sedative in accordance with current practice standards in neonatal foals
● administer slowly for first 3 - 5 minutes
bottle contains one dose of 250ml
for use by or under the direction of a veterinarian
Seramune I.V. Indications
for the treatment of failure of passive transfer in neonatal foals
do not mix with other products, except as specified on the label
in case of human exposure, contact a physician
with any serum product, adverse reactions may occur; in case of reactions, stop treatment and administer epinephrine
VLN/PCN 328/3607.00
250mL
sera, inc., po box 15866, shawnee mission, kansas 66285-5866 usa
913-541-1307
CPN: 1498000.1
P.O. BOX 15866, SHAWNEE MISSION, KS, 66285-5866
| Telephone: | 913-541-1307 | |
| Toll-Free: | 800-552-3984 | |
| Fax: | 913-541-1712 | |
| Website: | www.seramune.com | |
| Email: | info@seramune.com |
 |
Every effort has been made to ensure the accuracy of the Seramune I.V. information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert. |
Copyright © 2018 North American Compendiums. Updated: 2018-08-01
